APA (7th ed.) Citation

JS, R., I, C., M, C., AC, V., MB, F., CL, A., . . . M, B. (2022). Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option. Case reports in oncology, 15(3), 960. https://doi.org/10.1159/000526533

Chicago Style (17th ed.) Citation

JS, Reis, et al. "Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option." Case Reports in Oncology 15, no. 3 (2022): 960. https://doi.org/10.1159/000526533.

MLA (9th ed.) Citation

JS, Reis, et al. "Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option." Case Reports in Oncology, vol. 15, no. 3, 2022, p. 960, https://doi.org/10.1159/000526533.